resveratrol has been researched along with ATLL in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Harasawa, H; Hayashibara, T; Kamihira, S; Maita, T; Miyanishi, T; Nakayama, S; Sugahara, K; Tomonaga, M; Tsuruda, K; Yamada, Y | 1 |
Basile, A; Cecchinato, V; Chiaramonte, R; Comi, P; Cristofaro, B; Nizzardo, M; Sherbet, GV | 1 |
Ausserlechner, MJ; Bernhard, D; Csordas, A; Greil, R; Hübl, H; Kofler, R; Tinhofer, I; Tonko, M | 1 |
3 other study(ies) available for resveratrol and ATLL
Article | Year |
---|---|
Resveratrol induces downregulation in survivin expression and apoptosis in HTLV-1-infected cell lines: a prospective agent for adult T cell leukemia chemotherapy.
Topics: Adult; Annexin A5; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Line; Cysteine Proteinase Inhibitors; Down-Regulation; Flow Cytometry; Gene Expression; HTLV-I Infections; Humans; Inhibitor of Apoptosis Proteins; Leukemia-Lymphoma, Adult T-Cell; Microtubule-Associated Proteins; Neoplasm Proteins; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Stilbenes; Survivin | 2002 |
Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells.
Topics: Anticarcinogenic Agents; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Enzyme Activation; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Leukemia-Lymphoma, Adult T-Cell; Lithium Chloride; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Phytoalexins; Proto-Oncogene Proteins c-akt; Receptors, Notch; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; Sesquiterpenes; Signal Transduction; Stilbenes; Terpenes; Time Factors; Tumor Suppressor Protein p53 | 2007 |
Resveratrol causes arrest in the S-phase prior to Fas-independent apoptosis in CEM-C7H2 acute leukemia cells.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; Blotting, Western; Caspase Inhibitors; Caspases; Cell Separation; Dose-Response Relationship, Drug; Doxycycline; Fas Ligand Protein; fas Receptor; Flow Cytometry; Humans; Interphase; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Recombinant Fusion Proteins; Resveratrol; S Phase; Stilbenes; Time Factors; Transfection; Transgenes; Tumor Cells, Cultured | 2000 |